Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The NHS Information Centre has published a report on the cost of prescribing for diabetes in England over the period 2005/2006 to 2010/2011.
Some of the following key results have been presented (taken directly from source):
? Diabetes prevalence in England increased from 3.6% in 2005/6 to 4.3% in 2009/10.
? ?Drugs for diabetes' is the BNF section of highest cost and greatest increase in cost in primary care in England over the last year.
? In 2010/11 there were 38.3 million items prescribed for diabetes at a net ingredient cost of ?725.1 million.
? Prescribing for diabetes accounted for 4.1% of items and 8.4% of the total cost of prescribing in 2010/11 compared with 3.7% and 6.6% in 2005/6.
? Use of oral antidiabetic metformin rose from 8.6 million items in 2005/6 to 14.6 million items in 2010/11. This follows NICE's recommendation that this drug should be first choice for oral therapy.
Some of the following key results have been presented (taken directly from source):
? Diabetes prevalence in England increased from 3.6% in 2005/6 to 4.3% in 2009/10.
? ?Drugs for diabetes' is the BNF section of highest cost and greatest increase in cost in primary care in England over the last year.
? In 2010/11 there were 38.3 million items prescribed for diabetes at a net ingredient cost of ?725.1 million.
? Prescribing for diabetes accounted for 4.1% of items and 8.4% of the total cost of prescribing in 2010/11 compared with 3.7% and 6.6% in 2005/6.
? Use of oral antidiabetic metformin rose from 8.6 million items in 2005/6 to 14.6 million items in 2010/11. This follows NICE's recommendation that this drug should be first choice for oral therapy.